Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Performance of COVIDISC Rapid Test for Diagnosis of SARS-CoV-2

NCT04703140 is registered in ClinicalTrials.gov with CMC Ambroise Paré as lead sponsor.

NCT NCT04703140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04703140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Performance of COVIDISC Rapid Test for Diagnosis of SARS-CoV-2
Lead sponsor
CMC Ambroise Paré
Phase
Not applicable
Overall status
Terminated
Start date
January 27, 2021
Completion date
May 4, 2021
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2